Study of Nasal Ventilation In Preterm Infants To Decrease Time on The Respirator

NCT ID: NCT01440647

Last Updated: 2013-03-12

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-11-30

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Very premature infants often cannot breathe on their own and require assistance with a respirator. Conventional respirators deliver air or oxygen via a breathing tube placed through the mouth to the airway (endotracheal tube). A prolonged use of an endotracheal tube is associated with injury to the lungs. Currently, a premature baby has to be ventilated through an endotracheal tube until he/she can fully breathe independently. In the current study, in order to shorten the time with an endotracheal tube, we utilized an alternative, less invasive ventilation procedure, nasal intermittent positive pressure ventilation (NIPPV). This procedure provides help with breathing, but requires only nasal, not endotracheal tubes. We hypothesized that NIPPV might help babies breathe, at an early stage in their recovery, when they could not breathe independently yet. Thus, by switching babies at this early stage from a regular respirator to NIPPV, we should be able to shorten the use of an injurious endotracheal tube.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchopulmonary Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NIPPV

Extubation to NIPPV (nasal intermittent positive pressure ventilation)

Group Type EXPERIMENTAL

Extubation to NIPPV

Intervention Type PROCEDURE

After extubation infants were placed on NIPPV as soon as all the extubation criteria were met

CPAP

After extubation this arm was placed on CPAP (continuous positive airway pressure) and was not offered NIPPV in the first month on life

Group Type ACTIVE_COMPARATOR

Extubation to CPAP

Intervention Type PROCEDURE

After extubation infants were placed on CPAP

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extubation to NIPPV

After extubation infants were placed on NIPPV as soon as all the extubation criteria were met

Intervention Type PROCEDURE

Extubation to CPAP

After extubation infants were placed on CPAP

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

NIPPV CPAP

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gestational age 24 wks and 0 days through 27 wks and 6 days by obstetric criteria.
* Infants who are intubated for respiratory distress and received surfactant within 48 hrs of life.
* Infants whose ventilator settings are: ventilatory rate ≥ 26 breaths per minute. If the baby is on the high frequency oscillatory ventilator (HFOV) settings are MAP(mean airway pressure) ≥ 9, amplitude ≥ 2xMAP and frequency ≤ 13 Hertz.
* Infants who have never been previously extubated.

Exclusion Criteria

* Infants enrolled in competing trials.
* Participation refused by parent/attending physician/ parent unavailable for consent.
* Infants with any major congenital abnormality.
* Postoperative patients from any surgery.
* Infants in extremis/decided upon not to receive intensive care.
* Ventilator settings lower than the intervention group.
Maximum Eligible Age

48 Hours

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Women and Infants Hospital of Rhode Island

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Olga Sorina

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olga A DeSimone, MD

Role: PRINCIPAL_INVESTIGATOR

The Floating Hospital for Children at Tufts Medical Center

Abbot R Laptook, MD

Role: STUDY_DIRECTOR

Women and Infants Hospital of RI

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Women and Infants Hospital of RI

Providence, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07-0090

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.